About infinit Bio

infinit Bio manufactures psychedelics through biosynthesis. Building the first, in-vitro (cell-free) biomanufacturing platform allows infinit Bio to unchain psychedelic therapy developers from the old pharma supply- and value-chain.

Company Highlights
Year Founded

2021

icon-altEmployees

1

Location (HQ)

DEU

Since Last Funding

2 years 5 months

Monthly Website Visitors

1.1K

icon-altTotal Investment Amt

$200K

Last Funding Round

Pre Seed

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Manufacturing

Biotechnology Research

Biotechnology